Ligand validation:3W4T

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3W4T designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3W4T_OLC_A_502	35%	52%	0.174	0.864	0.89	0.98	1	2	1	0	100%	1
3W4T_OLC_A_501	22%	79%	0.185	0.874	0.23	0.62	-	-	1	0	60%	0.6
3W4T_OLC_A_506	20%	84%	0.187	0.848	0.23	0.52	-	-	2	0	68%	0.68
3W4T_OLC_A_508	19%	82%	0.184	0.829	0.23	0.56	-	-	4	0	72%	0.72
3W4T_OLC_A_507	11%	74%	0.234	0.842	0.33	0.67	-	-	4	0	48%	0.48
3W4T_OLC_A_505	9%	85%	0.268	0.836	0.26	0.48	-	-	2	0	60%	0.6
3W4T_OLC_A_504	7%	87%	0.22	0.752	0.24	0.45	-	-	4	0	60%	0.6
3W4T_OLC_A_509	6%	84%	0.253	0.732	0.26	0.49	-	-	0	0	68%	0.68
3W4T_OLC_A_503	4%	81%	0.311	0.791	0.24	0.57	-	-	2	0	44%	0.44
3WBN_OLC_A_501	21%	60%	0.191	0.894	0.86	0.67	1	-	1	0	48%	0.48
3VVN_OLC_A_504	21%	85%	0.223	0.954	0.24	0.49	-	-	0	0	32%	0.32
3VVR_OLC_A_503	21%	66%	0.218	0.876	0.69	0.61	1	-	1	0	72%	0.72
3VVO_OLC_A_508	18%	86%	0.159	0.862	0.25	0.47	-	-	0	0	36%	0.36
3VVS_OLC_A_502	13%	54%	0.222	0.888	1.09	0.67	1	-	0	0	32%	0.32
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.